Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/202101
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lajarin Reinares, Maria | - |
dc.contributor.author | Naveira-Souto, Iria | - |
dc.contributor.author | Mallandrich Miret, Mireia | - |
dc.contributor.author | Suñer Carbó, J. (Joaquim) | - |
dc.contributor.author | Llagostera, Montserrat | - |
dc.contributor.author | Calvo, Maria Angels | - |
dc.contributor.author | Fernández Campos, Francisco | - |
dc.date.accessioned | 2023-09-20T09:54:56Z | - |
dc.date.available | 2023-09-20T09:54:56Z | - |
dc.date.issued | 2023-05-08 | - |
dc.identifier.issn | 1999-4923 | - |
dc.identifier.uri | http://hdl.handle.net/2445/202101 | - |
dc.description.abstract | Alternative formulations need to be developed to improve the efficacy of treatments administered via the vaginal route. Mucoadhesive gels with disulfiram, a molecule that was originally approved as an antialcoholism drug, offer an attractive alternative to treat vaginal candidiasis. The aim of the current study was to develop and optimize a mucoadhesive drug delivery system for the local administration of disulfiram. Such formulations were composed of polyethylene glycol and carrageenan to improve the mucoadhesive and mechanical properties and to prolong the residence time in the vaginal cavity. Microdilution susceptibility testing showed that these gels had antifungal activity against Candida albicans, Candida parapsilosis, and Nakaseomyces glabratus. The physicochemical properties of the gels were characterized, and the in vitro release and permeation profiles were investigated with vertical diffusion Franz cells. After quantification, it was determined that the amount of the drug retained in the pig vaginal epithelium was sufficient to treat candidiasis infection. Together, our findings suggest that mucoadhesive disulfiram gels have the potential to be an effective alternative treatment for vaginal candidiasis. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | MDPI | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/ 10.3390/pharmaceutics15051436 | - |
dc.relation.ispartof | Pharmaceutics, 2023, vol. 15, num. 5, p. 1436 | - |
dc.rights | cc-by (c) Lajarin Reinares, Maria et al., 2023 | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.source | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) | - |
dc.subject.classification | Candidiasi | - |
dc.subject.classification | Malalties de l'aparell genital femení | - |
dc.subject.other | Candidiasis | - |
dc.subject.other | Female reproductive system diseases | - |
dc.title | Repurposing Disulfiram as an Antifungal Agent: Development of a New Disulfiram Vaginal Mucoadhesive Gel | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 734395 | - |
dc.date.updated | 2023-09-20T09:54:56Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
734395.pdf | 2.7 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License